← Leaderboards
Rachel S Friedman
National Jewish Health
$4,745,984
Attributed
$4,977,623
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $674.1K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,977,623 · 4
By mechanism
R01$3,642,594 · 1
R21$1,335,029 · 3
Top collaborators
- James Scott-Browne2 shared
Most similar at National Jewish Health
Same institution · by research overlap
- John C. Cambier$24,404,039
- Jordan Jacobelli$4,597,785
- Christina Carroll Leslie$11,280,080
- Julita A Ramirez$400,115
- Shaodong Dai$4,912,737
Others in their field
Top investigators on “Islets Of Langerhans”
- William R Clarke · University Of Iowa$34,851,026
- Joyce Carol Niland · City Of Hope/Beckman Research Institute$33,680,774
- Klaus H. Kaestner · University Of Pennsylvania$31,157,346
- Mark A Magnuson · Vanderbilt University$29,680,680
- Ali Naji · University Of Pennsylvania$28,189,073
- Alvin Carter Powers · Veterans Health Administration$22,544,115
Research focus
Islets Of LangerhansInsulinInsulin-Dependent Diabetes MellitusBeta CellIsletT-LymphocyteCellsDisease ProgressionImmuneCytokineMediatingImmune ResponseInfiltrationPancreasInsulin Dependent Diabetes Mellitus OnsetPreventProductionSingle-Cell Rna SequencingInbred Nod MiceIn VivoFamilyAutoantibodiesCell PhysiologyApoptotic
Grant awards (14)
Mertk Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$435,393
R01 · FY2025 · DK · contact PI
Mertk Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$427,237
R01 · FY2024 · DK · contact PI
Single Cell Genomics to Resolve Control of Immune Cell Function During Type 1 Diabetes$243,594
R21 · FY2024 · AI
Mertk Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$454,400
R01 · FY2023 · DK · contact PI
Single Cell Genomics to Resolve Control of Immune Cell Function During Type 1 Diabetes$219,685
R21 · FY2023 · AI
MerTK Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$433,854
R01 · FY2021 · DK · contact PI
MerTK Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$445,134
R01 · FY2020 · DK · contact PI
MerTK Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$454,575
R01 · FY2019 · DK · contact PI
MerTK Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$479,122
R01 · FY2018 · DK · contact PI
MerTK Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes$512,879
R01 · FY2017 · DK · contact PI
Role of Formins in Islet Infiltration in Type 1 Diabetes$237,750
R21 · FY2016 · AI · contact PI
Role of Islet-Infiltrating Lymphocytes in Obesity$237,750
R21 · FY2016 · AI · contact PI
Role of Islet-Infiltrating Lymphocytes in Obesity$198,125
R21 · FY2015 · AI · contact PI
Role of Formins in Islet Infiltration in Type 1 Diabetes$198,125
R21 · FY2015 · AI · contact PI